how to invest in glp-1 Investing Drugs: Eli Lilly, Novo Nordisk, and Viking Therapeutics in 2026 - News and Statistics How to Invest in Weight

The accumulation of long-term safety data and a comprehensive assessment of their clinical utility remain pressing challenges

GLP-1 medications like semaglutide have shown remarkable efficacy for weight management, with clinical trials demonstrating up to 22% body weight reduction over 68 weeks

The triple receptor activation produces even more aggressive appetite suppression, which correlates with more pronounced gastric emptying delays

Excess skin on the abdomen: A similar process occurs in the abdominal area

PubMed Central PMCID: PMC4995099

some patients may experience mild nausea (with or without vomiting) and abdominal pain that improves with use